News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on OncoSil Medical.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Good golly Miss Molly! Emyria says Ecstasy works for PTSD, months after treatment
News
Closing Bell: ASX bows out lower on last day of 2024, its best year since 2021
Health & Biotech
Health Check: Hearts aflutter as Echo IQ aces deal with major US teaching hospital
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
Health Check: The Winner Takes It All as US investors back advanced biotech plays
Health & Biotech
MoneyTalks: Pengana’s James McDonald reveals his top three ASX biotechs
Health & Biotech
Alive and Kicking: Respiri promises breath of life to bottom line after inking US distribution deal
News
Closing Bell: Origin, Cochlear dive on earnings; RBA rate cut looks less likely after jobs report
Health & Biotech
ASX Health Stocks: PYC to start trials for rare eye disease; OncoSil device successful in tumour removal
Health & Biotech
July Health Winners: Oncosil, Zelira lead as ASX biotechs power through another strong month
News
ASX July Winners: The best 50 stocks in a strong month for markets
Health & Biotech
Check Up: Europe delivers blow to Alzheimer’s research; and recent ASX health stock winners
News
Market Highlights: Wall Street in a sea of red, and cannabis stocks in focus after US report
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: ASX tumbles on Fedspeak; gold and oil jump as Middle East tension escalates
News
Market Highlights: Big Tech rebounds sharply, Costco in the gold game, and 5 small caps to watch today
News
